Clinical Trial

Molecular Study and Precision Medicine for Colorectal Cancer

Study acronym: MSPM
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2024 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Researchers collect specimens from advanced or recurrent colorectal cancer (CRC) patients to conduct molecular profiling and establish tumor organoids (PDOs)/ patient-derived xenografts (PDXs). The aim of this study is to identify clinical actionable targets and predict in vivo response of the tumor to targeted drugs by using PDOs/ PDXs. And the above-mentioned studies will provide the patients with potential personalized cancer treatment options.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05883683
Lead Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions Advanced Colorectal Carcinoma, Recurrent Colorectal Carcinoma
Enrollment 100 participants
Start Date 2024-10-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-24